Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay

OBJECTIVE: We assessed the clinical performance of novel Roche Elecsys SARS-CoV-2 Antigen fully automated electrochemiluminescence immunoassay (ECLIA). DESIGN AND METHODS: We tested 160 subjects, 110 (68.8%), with positive molecular test for SARS-CoV-2 infection in nasopharyngeal samples, with Alton...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvagno, Gian Luca, Pighi, Laura, De Nitto, Simone, Lippi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760093/
https://www.ncbi.nlm.nih.gov/pubmed/35071720
http://dx.doi.org/10.1016/j.plabm.2022.e00265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760093/
https://www.ncbi.nlm.nih.gov/pubmed/35071720
http://dx.doi.org/10.1016/j.plabm.2022.e00265

Ejemplares similares